Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Biphasic insulin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Mixtard 30Biphasic Insulin | 100 IU/mL Suspension for Injection (SC) [30% as soluble insulim human/70% as isophane insulin human]Type I glass vial closed with a disc (bromobutyl/isoprene rubber) and a protective tamper-proof plastic cap containing 10 mL of Suspension (Box of 1's) | RxVAT-exempt | Novo Nordisk Production SASFrance | Novo Nordisk Pharmaceuticals (Philippines), Inc. | BR-1220 | Jun 2, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .